|
Jul 25
|
3 Reasons to Avoid PRVA and 1 Stock to Buy Instead
|
|
Jul 21
|
Why Privia Health (PRVA) Stock Is Up Today
|
|
Jul 14
|
1 Stock Under $50 with Competitive Advantages and 2 to Steer Clear Of
|
|
Jul 10
|
Privia Health to Report Second Quarter 2025 Results on Thursday, August 7
|
|
Jul 4
|
Shoals Technologies Group Leads These 3 Stocks Estimated Below Intrinsic Value
|
|
Jul 4
|
Undervalued Stock Estimates For Consideration In July 2025
|
|
Jul 3
|
3 Stocks Estimated To Be Trading At Discounts Of Up To 44% Below Intrinsic Value
|
|
Jul 3
|
3 Noteworthy Stocks Estimated To Be Trading At Discounts Of Up To 32.5%
|
|
Jul 1
|
3 Stocks Estimated To Be Trading Below Fair Value By Up To 49.9%
|
|
Jul 1
|
Are Investors Undervaluing Privia Health Group, Inc. (NASDAQ:PRVA) By 44%?
|
|
Jun 27
|
The Top 5 Analyst Questions From Privia Health’s Q1 Earnings Call
|
|
Jun 18
|
3 Small-Cap Stocks in Hot Water
|
|
Jun 17
|
Privia Health Group, Inc. (PRVA) Earns Top Pick Status from TD Cowen
|
|
Jun 17
|
Q1 Rundown: Omnicell (NASDAQ:OMCL) Vs Other Healthcare Technology for Providers Stocks
|
|
Jun 5
|
PRVA Q1 Earnings Call: Arizona Expansion and Value-Based Care Execution
|
|
Jun 3
|
1 of Wall Street’s Favorite Stock on Our Watchlist and 2 to Think Twice About
|
|
May 28
|
Barclays Raises Privia Health (PRVA) PT to $24 on Strong Q1 Fee-for-Service Performance
|
|
May 20
|
3 Healthcare Stocks with Mounting Challenges
|
|
May 12
|
3 Dawdling Stocks with Mounting Challenges
|
|
May 10
|
Privia Health Group First Quarter 2025 Earnings: Revenues Beat Expectations, EPS Lags
|